Showing 371-380 of 3290 results for "".
What’s the Latest in Hair Management?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/whats-the-latest-in-hair-management/20113/Chytra Anand, MD, Neil Sadick, MD, and Brooke Jackson, MD offer insights on the best approaches to managing hair from global clinical experience to strategies for understanding the needs of each individual patient, they share tips to improve clinical outcomes.Antimicrobial Resistance and Psoriasis Remission
https://practicaldermatology.com/series/the-practical-dermatology-podcast/antimicrobial-resistance-and-psoriasis-remission/39042/Jason E. Hawkes, MD, MS, FAAD, discusses a recent consensus paper defining on-treatment remission for plaque psoriasis, and Theodore Rosen, MD, FAAD, joins associate medical editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss the threat posed by antimicrobial resistance and play “Two Truths and aHS Tips and Lizards
https://practicaldermatology.com/series/the-practical-dermatology-podcast/hs-tips-and-lizards/35858/The latest news and updates, plus a psoriasis update from Jashin J. Wu, MD, FAAD, at Music City SCALE, and Jennifer L. Hsiao, MD, joins Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, to discuss treating hidradenitis suppurativa and play a game of "Two Truths and a Lie."Psoriasis Challenges and Alopecia Areata Advances
https://reachmd.com/programs/practical-dermatology/psoriasis-challenges-and-alopecia-areata-advances/39885/Mona Shahriari, MD, FAAD, talks about the challenges psoriasis poses in certain parts of the body such as the scalp and nails, plus Brittany Craiglow, MD, FAAD, joins Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, to discuss the latest advances in alopecia areata.Scientifically Speaking: Managing Hair Loss Beyond PRP
https://practicaldermatology.com/series/scientifically-speaking/cientifically-speaking-managing-hair-loss-beyond-prp/20035/From documentary photographs to the potential for exosomes and the role of prescription therapies, many hot topics have emerged in the field of hair restoration. Glynis Ablon, MD and Jeffrey Rapaport, MD talk to host Joel L. Cohen, MD about clinical considerations beyond PRP.Various Skin Cancer Therapies Covered at Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/various-skin-cancer-therapies-covered-at-maui-derm/32915/With a theme of understanding the various options available for treatment of skin cancers and selecting the correct ones for each case, George Martin, MD, Ted Rosen, MD, and Emily Ruiz, MD, MPH, presented “Cutaneous Oncology Update 2025” at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.Hidradenitis Suppurativa: A Patient’s Perspective
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-patients-perspective/27171/Adam Friedman, MD, FAAD, presents a first-hand account of a patient living with hidradenitis suppurativa (HS).Scientifically Speaking: Correcting and Avoiding Complications in Dark Skin Tones, Part 2 of 2
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-correcting-and-avoiding-complications-in-dark-skin-tones-part-2-of-2/19898/Advancements in energy-based devices mean that these tools can be used across a range of skin tones. But complications can and do still occur. In part two of a discussion on EBDs used in darker skin types, host Joel L. Cohen, MD reviews cases with Michelle Henry, MD, Omar Ibrahimi, MD, PhD, and JennRevealed: The Two Hottest New Skin Cancer Ingredients
https://practicaldermatology.com/conferences/scale-2023/revealed-the-two-hottest-new-skin-cancer-ingredients/20202/Todd Schlesinger, MD, discusses the growing role of exosomes and cannabidiol (CBD) in dermatology.Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/annual-trends-in-medicare-part-d-prescription-claims-for-guselkumab-20182020/28861/Jachin Wu, MD, FAAD, and colleagues talk about Medicare claims for guselkumab